Internal Server Error

Ergomed - About the company

Ergomed is an acquired company based in Guildford (United Kingdom), founded in 1997. It operates as a Clinical CRO specializing in oncology and rare diseases. Ergomed has raised an undisclosed amount in funding. The company has 339 active competitors, including 14 funded and 112 that have exited. Its top competitors include companies like Parexel, Celgene and Veristat.

Company Details

Ergomed is a CRO operating in 50+ countries with two complementary businesses. As part of its co-development business, the company offers drug development services in exchange for revenues and out-licensing milestones w.r.t the sale and development of the product. The company has signed 5 such deals so far with different pharma companies. The company has acquired Haemostatix, along with a pipeline of proprietary development products for haemostasis in surgical settings.
Registered Address
1 OCCAM COURT,SURREY RESEARCH PARK,GUILDFORD,ENGLAND,GU2 7HJ
Key Metrics
Founded Year
1997
Location
Guildford, United Kingdom
Stage
Acquired
Latest Funding Round
Ranked
Annual Revenue
£100M - £500M as on Dec 31, 2022
Employee Count
720 as on May 31, 2026
Investment & Acquisitions
Similar Companies
Exit Details
Acquired by Permira (Sep 04, 2023)

Ergomed's acquisition details

Ergomed got acquired by Permira on Sep 04, 2023 at an acquisition amount of $*****.
Click here to take a look at Ergomed's acquisition in detail
Sign up to download Ergomed's company profile

Ergomed's funding and investors

Ergomed has raised funding over 2 rounds. Its first funding round was on 2005. Ergomed has 1 institutional investor.

Here is the list of recent funding rounds of Ergomed:
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Feb 01, 2018
3517945
Post IPO
5221475
7247397
5981552
5720712
2005
1123
Series A
3908
3636
9704
lockAccess funding benchmarks and valuations. Sign up today!

Ergomed's founders and board of directors

Founder? Claim Profile

Ergomed's employee count trend

Ergomed has 720 employees as of May 26. Here is Ergomed's employee count trend over the years:
Employee count trend for Ergomed
lockUncover Ergomed's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Ergomed's Competitors and alternates

Top competitors of Ergomed include Parexel, Celgene and Veristat. Here is the list of Top 10 competitors of Ergomed, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Parexel
Parexel
1983, Waltham (United States), Acquired
Global full-service CRO
-
61/100
2nd
Logo for Celgene
Celgene
1986, Summit (United States), Acquired
Developer of therapies for treating cancer and inflammatory diseases
$45M
61/100
3rd
Logo for Veristat
Veristat
1994, Southborough (United States), Acquired
Clinical research organization accelerating complex therapies through strategic planning and execution
-
60/100
4th
Logo for Siro Clinpharm
Siro Clinpharm
2000, Thane (India), Acquired
Company offering clinical development services
$5.25M
60/100
5th
Logo for TFS
TFS
1996, Lund (Sweden), Acquired
A global mid-service CRO providing clinical research services
-
59/100
6th
Logo for Syneos Health
Syneos Health
1984, Raleigh (United States), Public
Provider of CRO clinical development
-
58/100
7th
Logo for Premier Research
Premier Research
1989, Durham (United States), Public
Provider of clinical trial CRO services
-
55/100
8th
Logo for Biorasi
Biorasi
2002, Miami (United States), Acquired
CRO delivering reliable, flexible, transparent clinical trials with scientific excellence
-
-
54/100
9th
Logo for ClinChoice
ClinChoice
1995, Fort Washington (United States), Series E
CRO focused on data management, regulatory affairs and consulting services
$212M
53/100
10th
Logo for Worldwide Clinical Trials
Worldwide Clinical Trials
1986, Beverly Hills (United States), Acquired
Global CRO providing personalized support for clinical trials across diverse therapeutic areas
-
52/100
21st
Logo for Ergomed
Ergomed
1997, Guildford (United Kingdom), Acquired
Clinical CRO specializing in oncology and rare diseases
-
43/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Ergomed's competitors? Click here to see the top ones

Ergomed's Investments and acquisitions

Ergomed has made 1 investments in companies including Asarina Pharma. Ergomed has also acquired 7 companies including Panacea and ADAMAS Consulting.
Here is the list of investments & acquisitions:lockFilter this list
Date of Investment/Acquisition
Type
Company Name
Founded Year
Location
Oct 10, 2023
Acquisition
2008
Douglas (United Kingdom)
Feb 09, 2022
Acquisition
1997
Crowthorne (United Kingdom)
Dec 14, 2020
Acquisition
1997
Houston (United States)
lockWant to know more about where corporates are investing? Sign up today!
See all acquisitions by Ergomed

Reports related to Ergomed

Here is the latest report on Ergomed's geography:

News related to Ergomed

lockFilter this list
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Ergomed

Explore our recently published companies
  • Nurture Hospital - Bengaluru based, 2023 founded, Unfunded company
  • Yobedoo - Sweden based, 2026 founded, Unfunded company
  • Dalcott - 2026 founded, Unfunded company
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford